These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1048 related items for PubMed ID: 28852861

  • 1. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.
    Nishino K, Nishida A, Inoue R, Kawada Y, Ohno M, Sakai S, Inatomi O, Bamba S, Sugimoto M, Kawahara M, Naito Y, Andoh A.
    J Gastroenterol; 2018 Jan; 53(1):95-106. PubMed ID: 28852861
    [Abstract] [Full Text] [Related]

  • 2. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
    Ma HQ, Yu TT, Zhao XJ, Zhang Y, Zhang HJ.
    World J Gastroenterol; 2018 Apr 07; 24(13):1464-1477. PubMed ID: 29632427
    [Abstract] [Full Text] [Related]

  • 3. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid.
    Kabeerdoss J, Jayakanthan P, Pugazhendhi S, Ramakrishna BS.
    Indian J Med Res; 2015 Jul 07; 142(1):23-32. PubMed ID: 26261163
    [Abstract] [Full Text] [Related]

  • 4. Microbiome Survey of the Inflamed and Noninflamed Gut at Different Compartments Within the Gastrointestinal Tract of Inflammatory Bowel Disease Patients.
    Forbes JD, Van Domselaar G, Bernstein CN.
    Inflamm Bowel Dis; 2016 Apr 07; 22(4):817-25. PubMed ID: 26937623
    [Abstract] [Full Text] [Related]

  • 5. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
    Takahashi K, Nishida A, Fujimoto T, Fujii M, Shioya M, Imaeda H, Inatomi O, Bamba S, Sugimoto M, Andoh A.
    Digestion; 2016 Apr 07; 93(1):59-65. PubMed ID: 26789999
    [Abstract] [Full Text] [Related]

  • 6. Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders.
    Teofani A, Marafini I, Laudisi F, Pietrucci D, Salvatori S, Unida V, Biocca S, Monteleone G, Desideri A.
    Nutrients; 2022 Jan 08; 14(2):. PubMed ID: 35057440
    [Abstract] [Full Text] [Related]

  • 7. A microbial signature for Crohn's disease.
    Pascal V, Pozuelo M, Borruel N, Casellas F, Campos D, Santiago A, Martinez X, Varela E, Sarrabayrouse G, Machiels K, Vermeire S, Sokol H, Guarner F, Manichanh C.
    Gut; 2017 May 08; 66(5):813-822. PubMed ID: 28179361
    [Abstract] [Full Text] [Related]

  • 8. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease.
    Walker AW, Sanderson JD, Churcher C, Parkes GC, Hudspith BN, Rayment N, Brostoff J, Parkhill J, Dougan G, Petrovska L.
    BMC Microbiol; 2011 Jan 10; 11():7. PubMed ID: 21219646
    [Abstract] [Full Text] [Related]

  • 9. Molecular profiling of mucosal tissue associated microbiota in patients manifesting acute exacerbations and remission stage of ulcerative colitis.
    Walujkar SA, Kumbhare SV, Marathe NP, Patangia DV, Lawate PS, Bharadwaj RS, Shouche YS.
    World J Microbiol Biotechnol; 2018 May 23; 34(6):76. PubMed ID: 29796862
    [Abstract] [Full Text] [Related]

  • 10. Persistent Diarrhea in Patients With Crohn's Disease After Mucosal Healing Is Associated With Lower Diversity of the Intestinal Microbiome and Increased Dysbiosis.
    Boland K, Bedrani L, Turpin W, Kabakchiev B, Stempak J, Borowski K, Nguyen G, Steinhart AH, Smith MI, Croitoru K, Silverberg MS.
    Clin Gastroenterol Hepatol; 2021 Feb 23; 19(2):296-304.e3. PubMed ID: 32220613
    [Abstract] [Full Text] [Related]

  • 11. Characterization of fungal dysbiosis in Japanese patients with inflammatory bowel disease.
    Imai T, Inoue R, Kawada Y, Morita Y, Inatomi O, Nishida A, Bamba S, Kawahara M, Andoh A.
    J Gastroenterol; 2019 Feb 23; 54(2):149-159. PubMed ID: 30478724
    [Abstract] [Full Text] [Related]

  • 12. Adolescent gut microbiome imbalance and its association with immune response in inflammatory bowel diseases and obesity.
    Joo M, Nam S.
    BMC Microbiol; 2024 Jul 19; 24(1):268. PubMed ID: 39030520
    [Abstract] [Full Text] [Related]

  • 13. Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn's Disease.
    Liu B, Ye D, Yang H, Song J, Sun X, Mao Y, He Z.
    Front Immunol; 2022 Jul 19; 13():921546. PubMed ID: 35860271
    [Abstract] [Full Text] [Related]

  • 14. Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission.
    Pisani A, Rausch P, Bang C, Ellul S, Tabone T, Marantidis Cordina C, Zahra G, Franke A, Ellul P.
    Microbiol Spectr; 2022 Jun 29; 10(3):e0061622. PubMed ID: 35532243
    [Abstract] [Full Text] [Related]

  • 15. Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn's disease.
    Libertucci J, Dutta U, Kaur S, Jury J, Rossi L, Fontes ME, Shajib MS, Khan WI, Surette MG, Verdu EF, Armstrong D.
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep 01; 315(3):G420-G431. PubMed ID: 29848021
    [Abstract] [Full Text] [Related]

  • 16. Influence of Crohn's disease related polymorphisms in innate immune function on ileal microbiome.
    Li E, Zhang Y, Tian X, Wang X, Gathungu G, Wolber A, Shiekh SS, Sartor RB, Davidson NO, Ciorba MA, Zhu W, Nelson LM, Robertson CE, Frank DN.
    PLoS One; 2019 Sep 01; 14(2):e0213108. PubMed ID: 30818349
    [Abstract] [Full Text] [Related]

  • 17. Microbial Signatures and Innate Immune Gene Expression in Lamina Propria Phagocytes of Inflammatory Bowel Disease Patients.
    Dheer R, Davies JM, Quintero MA, Damas OM, Deshpande AR, Kerman DH, Sawyer WP, Pignac-Kobinger J, Ban Y, Fernandez I, Burgueno JF, Phillips MC, Abreu MT.
    Cell Mol Gastroenterol Hepatol; 2020 Sep 01; 9(3):387-402. PubMed ID: 31740421
    [Abstract] [Full Text] [Related]

  • 18. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
    Rojas-Feria M, Romero-García T, Fernández Caballero-Rico JÁ, Pastor Ramírez H, Avilés-Recio M, Castro-Fernandez M, Chueca Porcuna N, Romero-Gόmez M, García F, Grande L, Del Campo JA.
    World J Gastroenterol; 2018 Dec 14; 24(46):5223-5233. PubMed ID: 30581271
    [Abstract] [Full Text] [Related]

  • 19. Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients.
    Čipčić Paljetak H, Barešić A, Panek M, Perić M, Matijašić M, Lojkić I, Barišić A, Vranešić Bender D, Ljubas Kelečić D, Brinar M, Kalauz M, Miličević M, Grgić D, Turk N, Karas I, Čuković-Čavka S, Krznarić Ž, Verbanac D.
    Gut Microbes; 2022 Dec 14; 14(1):2083419. PubMed ID: 35695669
    [Abstract] [Full Text] [Related]

  • 20. Mucosal Barrier Depletion and Loss of Bacterial Diversity are Primary Abnormalities in Paediatric Ulcerative Colitis.
    Alipour M, Zaidi D, Valcheva R, Jovel J, Martínez I, Sergi C, Walter J, Mason AL, Wong GK, Dieleman LA, Carroll MW, Huynh HQ, Wine E.
    J Crohns Colitis; 2016 Apr 14; 10(4):462-71. PubMed ID: 26660940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.